| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |